These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 34753964)

  • 1. Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms.
    Shokri-Afra H; Alikhani A; Moradipoodeh B; Noorbakhsh F; Fakheri H; Moradi-Sardareh H
    Sci Rep; 2021 Nov; 11(1):22001. PubMed ID: 34753964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.
    Zerbato V; Di Bella S; Giuffrè M; Jaracz AW; Gobbo Y; Luppino D; Macor P; Segat L; Koncan R; D'Agaro P; Valentini M; Crocé LS; Ruscio M; Luzzati R
    World J Gastroenterol; 2021 Jun; 27(22):3130-3137. PubMed ID: 34168414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study.
    Cherubini F; Cristiano A; Valentini A; Bernardini S; Nuccetelli M
    Inflamm Res; 2021 Jun; 70(6):687-694. PubMed ID: 33956194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum.
    Klingberg E; Carlsten H; Hilme E; Hedberg M; Forsblad-d'Elia H
    Scand J Gastroenterol; 2012 Apr; 47(4):435-44. PubMed ID: 22229862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA; Leach ST; Day AS
    Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19.
    Lee A; Nahm CH; Lee JS; Lee MK; Lee KR
    J Clin Lab Anal; 2021 Nov; 35(11):e24004. PubMed ID: 34608677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases.
    Damms A; Bischoff SC
    Int J Colorectal Dis; 2008 Oct; 23(10):985-92. PubMed ID: 18629518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
    Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
    Chen CC; Huang JL; Chang CJ; Kong MS
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals.
    Heinzel S; Jureczek J; Kainulainen V; Nieminen AI; Suenkel U; von Thaler AK; Kaleta C; Eschweiler GW; Brockmann K; Aho VTE; Auvinen P; Maetzler W; Berg D; Scheperjans F
    Sci Rep; 2024 Jun; 14(1):13513. PubMed ID: 38866914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
    Broglie L; Rademaker A; Galvin J; Ray A; Tse WT; Duerst R; Schneiderman J; Kletzel M; Chaudhury S
    Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):169-174. PubMed ID: 29397331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease.
    Kennedy NA; Jones GR; Plevris N; Patenden R; Arnott ID; Lees CW
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2269-2276.e4. PubMed ID: 30772585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.
    Fukunaga S; Kuwaki K; Mitsuyama K; Takedatsu H; Yoshioka S; Yamasaki H; Yamauchi R; Mori A; Kakuma T; Tsuruta O; Torimura T
    Int J Mol Med; 2018 Jan; 41(1):107-118. PubMed ID: 29115397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
    Önal İK; Beyazit Y; Şener B; Savuk B; Özer Etık D; Sayilir A; Öztaş E; Torun S; Özderın Özın Y; Tunç Demırel B; Ülker A; Dağli Ü
    Turk J Gastroenterol; 2012; 23(5):509-14. PubMed ID: 23161295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease.
    Sipponen T; Savilahti E; Kärkkäinen P; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2008 Oct; 14(10):1392-8. PubMed ID: 18484671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies.
    Heilmann RM; Berghoff N; Mansell J; Grützner N; Parnell NK; Gurtner C; Suchodolski JS; Steiner JM
    J Vet Intern Med; 2018 Mar; 32(2):679-692. PubMed ID: 29460444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.
    Manz M; Burri E; Rothen C; Tchanguizi N; Niederberger C; Rossi L; Beglinger C; Lehmann FS
    BMC Gastroenterol; 2012 Jan; 12():5. PubMed ID: 22233279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin concentration is increased in children with celiac disease: relation with histopathological findings.
    Balamtekın N; Baysoy G; Uslu N; Orhan D; Akçören Z; Özen H; Gürakan F; Saltik-Temızel İN; Yüce A
    Turk J Gastroenterol; 2012; 23(5):503-8. PubMed ID: 23161294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.